Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C
Clinical trial NCT01760187 · COMPLETED
Trial details
- NCT number
- NCT01760187
- Sponsor
- Aegerion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-07
- Primary completion
- 2013-06-03
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.